Published by Peptide Protocols · Reviewed September 2026 · How we make these pages · Educational & research purposes only — not medical advice.
If Ozempic and Wegovy were the opening act of the weight-loss-medication era, Zepbound vs Wegovy is the main-event title fight everyone's Googling now. Same goal, two different molecules, one very direct head-to-head trial — and, refreshingly, an actual clear-ish answer. Let's break it down in plain English.
Want the deeper mechanism (and where the newer triple-agonists fit)? See tirzepatide vs semaglutide and retatrutide, the triple-G peptide.
This is the part the “Zepbound wins” headlines skip — and it genuinely matters:
Meanwhile Zepbound has its own bonus: it's also approved for obstructive sleep apnea in adults with obesity. So “better” really does depend on better for what.
Both are powerful appetite suppressants — and both can quietly take muscle along with fat if protein and resistance training don't come along. A bigger number on the scale isn't automatically a better body composition. Whichever you research, the muscle-protection playbook is the same, and it's exactly why our GLP-1 muscle-preservation guide exists.
Vial mg + bacteriostatic water mL + your target mcg → mL and U-100 syringe units, instantly. Free, no sign-up, 60+ research peptides preset — plus dedicated calculators and BAC-water charts for BPC-157, retatrutide, tirzepatide, semaglutide, tesamorelin and CJC-1295/ipamorelin.
Open the free peptide calculator →Research & educational use only — never medical advice.
Both carry high list prices, and out-of-pocket depends heavily on insurance and manufacturer savings programs. The “more effective” drug isn't more effective if you can't sustainably access it — so real-world availability and price belong in the decision right next to the trial data.
In the direct SURMOUNT-5 trial, Zepbound (tirzepatide) produced greater average weight loss than Wegovy (semaglutide) — about 20.2% vs 13.7%. Individual response still varies.
It's a dual GIP/GLP-1 agonist — it acts on two gut hormones instead of one. Wegovy targets GLP-1 alone.
Yes — it's approved to reduce cardiovascular risk and for a fatty liver indication, has a longer outcomes track record, and comes in a pill form. Zepbound is separately approved for obstructive sleep apnea.
That's a clinical decision. It depends on your goals (weight vs heart protection), health history, insurance, and whether you'll tolerate injections. Both require protecting muscle with protein and resistance training.
The Universal Logbook and reconstitution tools keep your notes clean and the math done for you across any compound you study.
Browse the shop on Etsy →We do not recommend or partner with any peptide supplier. Use the checklist instead: third-party COAs that match your batch and lot, stated purity, clear research-use labeling, real support and proper cold-chain shipping.
The supplier checklist →Educational content only. Confirm the legal status where you live before ordering anything.
The one formula, a BAC-water chart, and the 10 most-researched beginner peptides — the math done for you. Print it for the fridge.
🎁 Send me the free cheat sheet →